HomeEXECUTIVES

Category: EXECUTIVES

The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.

As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.

Avation Medical adds Vice President...

April 18, 2024

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

April 17, 2024

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical adds Vice President of Market Access

April 18, 2024

ForSight Robotics Expands Leadership Team with Appointment of Sharon Levita As CFO

Sharon Levita will lead ForSight Robotics’ strategic and financial operations, focusing on driving business strategies, expanding strategic partnerships, and managing financial and growth objectives.

July 17, 2023

ABIONYX Pharma announces the appointment of Laurent Guerci as Chief Digital & Innovation Officer

Laurent Guerci will be responsible for carrying out various projects to structure ABIONYX Pharma, in particular the digitalisation of the Group. ABIONYX Pharma's ambition, in support of its innovative biotherapies strategy, is to digitalise its internal processes, its exchanges with its pharmaceutical partners and to use its data capital through the use of Artificial Intelligence technologies to improve its know-how in pre-clinical and clinical studies and the development of innovative therapies, whether in sepsis, renal diseases or ophthalmology.

July 13, 2023

MG America Names New Sales Manager, Jim McKee, for Processing Division

Experienced equipment pro Jim McKee to oversee sales for the company’s portfolio of capsule fillers, check weighers, and material handling solutions.

July 11, 2023

Henry Schein Congratulates Dr. Louis W. Sullivan for Receiving a 2023 National Humanism in Medicine Medal, Awarded by The Arnold P. Gold Foundation

Medal recipients were recognized during The Gold Foundation’s Annual Gala held at the Ziegfeld Ballroom in New York City on June 20, 2023. In addition to Dr. Sullivan, honorees included: Dr. Gina S. Brown, Dean of the College of Nursing and Allied Health Sciences at Howard University; Dr. Richard I. Levin, President and CEO of The Gold Foundation; and Dr. Eileen Sullivan-Marx, Dean of the NYU Rory Meyers College of Nursing.

July 10, 2023

Deepa Prasad Appointed CFO of Secretome Therapeutics

"I am truly excited to be joining Secretome at this pivotal time in the company’s history. I believe that secretomes represent a true breakthrough in the field of cell-based therapy, and I look forward to helping Secretome transform the way we treat diseases," said Ms. Deepa Prasad.

June 26, 2023

Medtronic Board Appoints Greg Lewis as New Director | Effective June 26, 2023

Greg Lewis will serve on the Audit Committee and the Finance and Financial Risk Committee, effective June 26, 2023.

June 26, 2023

Preston S Klassen MD Appointed to the BOD of Regulus Therapeutics

Preston S Klassen MD recently joined Regulus Therapeutics as President and Head of Research and Development. Dr. Klassen is a nephrologist by training who brings over 20 years of experience in pharmaceuticals, including positions in leadership, medical affairs, and research and development across multiple therapeutic areas.

June 23, 2023

Ethypharm Announces Xavier LASSERRE as the New CCO | Leading Pharmaceutical Veteran

Xavier LASSERRE has a strong experience and expertise in the pharmaceutical industry, particularly in the European markets, both in the retail and hospital sectors.

June 23, 2023

Ferring Pharmaceuticals Appoints New Executive Chairman Among Key Changes to Board of Directors

Jean-Frédéric Paulsen has been appointed Executive Chairman of the Ferring Pharmaceuticals Group, as it enters a new phase of growth following the approval of two innovative medicines by the US Food and Drug Administration.

June 22, 2023